查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1676876

GMP 細胞庫服務市場按細胞類型、品質等級、服務類型、應用和最終用戶分類 - 2025-2030 年全球預測

GMP Cell Banking Services Market by Cell Type, Quality Grade, Service Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

GMP細胞銀行服務市場預計在 2024 年達到 9.6341 億美元，2025 年達到 10.7382 億美元，到 2030 年達到 18.9868 億美元，複合年成長率為 11.97%。

主要市場統計數據
基準年 2024 年 9.6341億美元
預計 2025 年 10.7382億美元
預測年份 2030 18.9868億美元
複合年成長率（%） 11.97％

隨著生物技術的發展，GMP 細胞庫服務已成為確保穩定供應用於各種應用的高品質細胞的關鍵組成部分。本報告提供了市場分析概述，從良好生產品管(GMP) 的角度探討了細胞庫的複雜性，並詳細介紹了服務如何發展以滿足監管要求和科學進步。隨著市場不斷擴大以滿足對先進療法和新型生物製劑日益成長的需求，維持強大的細胞庫至關重要。目前的環境不僅要求細胞處理和儲存的精確性，還需要全面了解操作、物流和技術挑戰。透過全面分析最近的趨勢、技術創新和監管變化，該分析提供了有關細胞銀行策略如何適應行業不斷變化的需求的寶貴見解。討論包括對服務模式、品質考量和營運準備的嚴格檢驗，從而為相關人員了解行業的發展歷程和預測未來發展方向奠定了堅實的基礎。本介紹為深入了解市場發展、策略性細分見解以及推動這一重要領域成長和創新的關鍵區域和企業動態奠定了基礎。

GMP細胞庫服務市場的轉型

過去十年，GMP細胞庫服務市場經歷了重大轉變。快速的技術進步和不斷發展的法律規範重新定義了行業標準和資源分配。這一演變的特點是整合了尖端自動化、增強的品管通訊協定以及戰略重點增強流程以滿足現代治療要求。這種轉變的背後是人們認知到技術創新必須與合規齊頭並進，促使行業參與者大力投資於支持效率和嚴格遵守法規的強大基礎設施。

從歷史角度來看，細胞銀行流程基本上是手動和被動的。這種變化不僅影響業務方式，也影響公司製定服務交付策略的方式。因此，許多組織現在使用流程最佳化工具和預測分析來最大限度地減少差異並提高生產力。監管機構也在這一轉變中發揮關鍵作用，發布更新的指導方針，迫使重新調整製造實踐。這個新框架強調可追溯性、彈性和擴充性，為未來的成長和創新定位市場。相關人員現在可以更好地管理風險和動態調整流程，確保他們的 GMP 實踐符合當前法規和未來行業趨勢。

GMP細胞庫服務關鍵部分分析

為了更深入分析GMP細胞庫服務市場，有必要考慮多層次的細分結構。根據細胞類型進行細分，將動物細胞與人類細胞進行對比，這表明市場研究必須考慮每個類別的獨特處理、加工和監管要求。同時，品質等級分類區分臨床級和研究級。雖然這兩個不同的部分都極為重要，但其合規性、精確度和營運監督水準卻不同。停產細胞庫、主細胞庫和工作細胞庫等服務類型細分的多樣性反映了產業參與者為最大限度提高產品品質和營運效率而採用的多層次複雜性和獨特方法。

此外，基於應用程式的細分提供了對特定最終用途應用程式的洞察，從而進一步對市場進行分層。例如，生物製藥生產可分為單株抗體生產和重組蛋白生產。這種細微的差異凸顯了這些產品在現代治療中所扮演的重要角色。研發應用正在深入研究突破性的治療方法，包括細胞療法、基因療法和幹細胞研究，每種治療方法都需要嚴格擴展和調整細胞庫通訊協定。同樣，組織工程應用突顯了在技術突破中迅速普及的新興領域，例如生物列印技術、器官移植解決方案和基於支架的應用。

基於最終用戶（例如合約研究組織、醫院、製藥公司、研究機構）的最後一層細分提供了誰從這些服務中受益的全面情況。按服務類型、品質、應用和最終用戶進行細分的相互作用不僅說明了市場固有的複雜性，而且還揭示了可能推動細胞銀行領域進一步創新和策略進步的新興趨勢。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性病的增多推動了對有效、高效細胞庫的需求
      • 隨著個人化醫療需求的增加，對 GMP 細胞庫服務的需求也隨之增加。
      • 全球生物製藥和醫藥投資不斷增加
    • 限制因素
      • 影響 GMP 細胞庫服務的成本影響與投資障礙
    • 機會
      • 技術進步提高了對 GMP 細胞庫準確性和可靠性的期望
      • 再生醫學和免疫療法的發展需要先進的細胞庫
    • 任務
      • 嚴格的 GMP 合規性和細胞庫核准監管要求
  • 市場區隔分析
    • 細胞類型：個人化醫療和再生醫學的擴大將增加對人體細胞的需求
    • 最終用戶：增加對製藥和生物製藥領域的投資，加強細胞庫基礎設施，
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. GMP 細胞銀行服務市場（依細胞類型）

  • 動物細胞
  • 人類細胞

7. GMP 細胞庫服務市場依品質等級分類

  • 臨床級
  • 研究級

8. GMP 細胞銀行服務市場依服務類型

  • 臨終細胞銀行
  • 主細胞庫
  • 工作細胞庫

9. GMP 細胞銀行服務市場（依應用）

  • 生物製藥製造
    • 單株抗體
    • 重組蛋白
  • 研究與開發
    • 細胞療法
    • 基因治療
    • 幹細胞研究
  • 組織工程
    • 生物列印技術
    • 器官移植解決方案
    • 基於支架的應用程式

第 10 章 GMP 細胞銀行服務市場（按最終用戶）

  • 合約研究組織
  • 醫院
  • 製藥公司
  • 研究組織

11. 美洲 GMP 細胞銀行服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區 GMP 細胞庫服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲 GMP 細胞庫服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • 53Biologics
  • Austrianova
  • Cell Culture Company, LLC
  • Charles River Laboratories
  • Clean Cells
  • Eurofins Scientific Limited
  • ExcellGene SA
  • Goodwin Biotechnology Inc.
  • Kaneka Eurogentec SA
  • Lonza Group Ltd.
  • Merck KGaA
  • NAOBIOS
  • PackGene Biotech lnc.
  • ProBio Biotech Corporation
  • RoslinCT
  • SGS Group
  • SK pharmteco Inc.
  • Takara Bio Inc.
  • Texcell SA
  • uBriGene Biosciences International Co.
  • ViruSure GmbH
  • Wacker Chemie AG
  • WuXi Biologics
Product Code: MRR-E336711C9F91

The GMP Cell Banking Services Market was valued at USD 963.41 million in 2024 and is projected to grow to USD 1,073.82 million in 2025, with a CAGR of 11.97%, reaching USD 1,898.68 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 963.41 million
Estimated Year [2025] USD 1,073.82 million
Forecast Year [2030] USD 1,898.68 million
CAGR (%) 11.97%

In the evolving landscape of biotechnology, GMP Cell Banking Services have emerged as a cornerstone for ensuring the consistent supply of high-quality cells for diverse applications. This report provides an analytical overview of the market, exploring the intricacies of cell banking from the perspective of Good Manufacturing Practice (GMP) and detailing how services have transformed to meet both regulatory demands and scientific advancements. As the market expands to accommodate the rising demand for advanced therapies and novel biopharmaceutical products, the need to maintain robust cell banking practices has become indispensable. The current environment demands not only precision in cell processing and storage but also a comprehensive understanding of the operational, logistical, and technical challenges involved. By synthesizing recent trends, technological innovations, and regulatory shifts, this analysis offers valuable insights into how cell banking strategies have adapted to meet evolving industry needs. The discussion encompasses a critical examination of service models, quality considerations, and operational readiness, thereby laying a solid foundation for stakeholders to appreciate where the industry has been and envision where it is headed. This introductory section sets the stage for a detailed exploration of the market's transformative shifts, strategic segmentation insights, and key regional as well as corporate dynamics that are driving growth and innovation in this vital sector.

Transformative Shifts in GMP Cell Banking Landscape

The GMP Cell Banking Services market has witnessed significant transformative shifts over the past decade. Rapid technological advancements and evolving regulatory frameworks have redefined industry standards and resource allocation. This evolution is characterized by the integration of state-of-the-art automation, enhanced quality control protocols, and a strategic focus on scaling processes to align with modern therapeutic requirements. Underpinning these changes is the recognition that innovation must go hand in hand with compliance, prompting industry participants to invest heavily in robust infrastructure that supports both efficiency and stringent regulatory adherence.

From a historical perspective, cell banking processes were largely manual and reactive, but today they have become a proactive, technology-driven discipline. The shift has influenced not only operational modalities but also how companies strategize their service offerings. As a result, many organizations are now leveraging process optimization tools and predictive analytics to minimize variability and enhance productivity. Regulatory bodies have also played a pivotal role in this shift, issuing updated guidelines that have forced a recalibration of manufacturing practices. This new framework emphasizes traceability, resilience, and scalability, positioning the market for future growth and innovation. Stakeholders are now better equipped to manage risk and adapt their processes dynamically, ensuring that their GMP practices remain aligned with both current regulations and future industry trends.

Key Segmentation Insights for GMP Cell Banking Services

A deeper analysis of the GMP Cell Banking Services market necessitates an examination of its multi-layer segmentation structure. The segmentation based on cell type contrasts between animal cells and human cells, indicating that market studies must account for the unique handling, processing, and regulatory requirements inherent in each category. In parallel, quality grade segmentation differentiates between clinical grade and research grade - two distinct segments that, while both crucial, require varied levels of compliance, precision, and operational oversight. The diverse nature of the service type segmentation, spanning end-of-production cell banking, master cell banking, and working cell banking, reflects the layered complexity and the tailored approaches industry players utilize to maximize both output quality and operational efficiency.

In addition, the segmentation based on application offers insight into specific end uses that further stratify the market. Biopharmaceutical production, for instance, is dissected into the production of monoclonal antibodies and recombinant proteins. This nuanced division highlights the critical role these products play in modern therapeutics. Research and development applications delve into breakthrough therapies including cell therapy, gene therapy, and stem cell research; each domain demands rigorous expansion and adaptation of cell banking protocols. Similarly, tissue engineering applications underscore emerging fields such as bioprinting technologies, organ transplant solutions, and scaffold-based applications - domains that are rapidly gaining traction amid technological breakthroughs.

A final layer of segmentation based on the end-user - which covers contract research organizations, hospitals, pharmaceutical companies, and research institutes - provides a comprehensive view of who is benefiting from these services. The interplay between service type, quality, application, and end-user segmentation not only illustrates the market's inherent complexity but also sheds light on emerging trends that are likely to drive further innovations and strategic advancements in the cell banking arena.

Based on Cell Type, market is studied across Animal Cells and Human Cells.

Based on Quality Grade, market is studied across Clinical Grade and Research Grade.

Based on Service Type, market is studied across End-of-Production Cell Banking, Master Cell Banking, and Working Cell Banking.

Based on Application, market is studied across Biopharmaceutical Production, Research & Development, and Tissue Engineering. The Biopharmaceutical Production is further studied across Monoclonal Antibodies and Recombinant Proteins. The Research & Development is further studied across Cell Therapy, Gene Therapy, and Stem Cell Research. The Tissue Engineering is further studied across Bioprinting Technologies, Organ Transplant Solutions, and Scaffold-Based Applications.

Based on End-User, market is studied across Contract Research Organizations, Hospitals, Pharmaceutical Companies, and Research Institutes.

Exploring Regional Dynamics in GMP Cell Banking Services

Regional characteristics significantly shape the competitive strategies and market performance in GMP Cell Banking Services. The market landscape in the Americas is defined by high investments in technology innovations and a strong regulatory environment, which collectively promote robust infrastructure development. In contrast, the combined markets of Europe, the Middle East, and Africa exhibit a complex interplay between longstanding regulatory frameworks and rapidly evolving technological standards. These regions are characterized by a mix of mature biopharmaceutical ecosystems and emerging economies, which together pave the way for diverse growth trajectories and strategic collaborations.

Asia-Pacific stands out for its dynamic growth fueled by increasing investments in biotechnology and research-oriented cellular therapies. The region's efforts in aligning with global GMP standards while encouraging local innovations have laid the groundwork for impressive scalability and high-capacity production. Each of these regions contributes distinctive insights: while the Americas lead in technological integration, Europe, the Middle East, and Africa bring innovative regulatory solutions to the fore, and Asia-Pacific champions scalability and emerging market solutions. Understanding these regional dynamics is crucial for stakeholders aiming to tailor their strategies to capture localized opportunities while maintaining a competitive edge in the global marketplace.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Driving Market Innovations

The market is populated by numerous leading companies that play a critical role in driving innovation and maintaining high standards in GMP Cell Banking Services. Industry players such as 53Biologics and Austrianova have fostered a culture of excellence through technological innovations that enhance process reliability and quality control. Companies like Cell Culture Company, LLC and Charles River Laboratories continue to set benchmarks in operational efficiency and regulatory compliance, while Clean Cells and Eurofins Scientific Limited bring valuable expertise in ensuring product integrity and safety throughout the cell banking lifecycle.

Notable companies including ExcellGene SA, Goodwin Biotechnology Inc., and Kaneka Eurogentec S.A. are examples of organizations that champion rigorous quality management systems. Further insights into market performance emerge from the contributions of industry leaders like Lonza Group Ltd., Merck KGaA, and NAOBIOS, who invest heavily in R&D and technological modernization. The presence of innovative players such as PackGene Biotech Inc., ProBio Biotech Corporation, and RoslinCT underscores the market's commitment to continuous improvement, while firms like SGS Group, SK pharmteco Inc., Takara Bio Inc., and Texcell SA collectively contribute to an ecosystem characterized by robust compliance and operational innovation.

Moreover, strategic insights have been reinforced by the collaborative efforts of uBriGene Biosciences International Co., ViruSure GmbH, Wacker Chemie AG, and WuXi Biologics. Each of these companies has significantly influenced market trends by integrating cutting-edge technology with advanced therapeutic practices and by setting industry standards that push the boundaries of what is possible in cell banking. Their collective contributions have laid the foundation for a dynamic market environment that is continually evolving to meet the demands of modern healthcare and scientific research.

The report delves into recent significant developments in the GMP Cell Banking Services Market, highlighting leading vendors and their innovative profiles. These include 53Biologics, Austrianova, Cell Culture Company, LLC, Charles River Laboratories, Clean Cells, Eurofins Scientific Limited, ExcellGene SA, Goodwin Biotechnology Inc., Kaneka Eurogentec S.A., Lonza Group Ltd., Merck KGaA, NAOBIOS, PackGene Biotech lnc., ProBio Biotech Corporation, RoslinCT, SGS Group, SK pharmteco Inc., Takara Bio Inc., Texcell SA, uBriGene Biosciences International Co., ViruSure GmbH, Wacker Chemie AG, and WuXi Biologics. Actionable Recommendations for Industry Leaders

Industry leaders must adopt a forward-thinking approach to thrive in an increasingly competitive GMP Cell Banking Services market. It is essential to invest in process automation and digitalization, which can streamline operations and enhance traceability across production phases. Leaders should prioritize the integration of advanced quality control measures and predictive analytics to minimize production variability while optimizing throughput.

An emphasis on strategic partnerships and collaborations is also paramount. By engaging with regulatory bodies, technology providers, and research institutions, companies can stay ahead of evolving compliance requirements and drive innovation collaboratively. Additionally, there is a critical need to diversify service portfolios to address the intricate demands of different end-user segments. This diversification includes tailoring offerings to specialized applications such as monoclonal antibody production, gene therapy advancements, and scaffold-based tissue engineering solutions.

Furthermore, continuous workforce training and development represent a vital component of maintaining industry leadership. Companies should foster environments that encourage knowledge sharing and cross-disciplinary expertise, thereby ensuring that teams remain agile and adept in implementing sophisticated GMP protocols. A proactive approach to market intelligence, combined with an investment in scalable infrastructure, will empower leaders to efficiently navigate the complexities of globalization and future-proof their operational strategies.

Conclusion: The Future of GMP Cell Banking Services

The evolution of GMP Cell Banking Services is marked by a synthesis of technological advancements, regulatory clarity, and strategic segmentation. The market's transformation from conventional approaches to a modern, technology-driven ecosystem has been accelerated by global trends and regional dynamics that cater to both mature and emerging biopharmaceutical requirements. This comprehensive examination of market trends, segmentation intricacies, and corporate dynamics has illuminated the path forward for stakeholders.

In summary, the ongoing innovation in cell banking is reshaping the landscape, enabling organizations to achieve greater efficiency, enhanced quality, and improved compliance with regulatory standards. Stakeholders are therefore better positioned to capitalize on emerging opportunities, ensuring that future manufacturing processes are not only robust and scalable, but also agile enough to adapt to the rapidly evolving scientific and regulatory environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases boosting the requirement for effective and efficient cell banks
      • 5.1.1.2. Increasing demand for personalized medicine enhances the need for GMP cell banking services
      • 5.1.1.3. Rising investment in biopharmaceuticals & pharmaceutical sectors across the globe
    • 5.1.2. Restraints
      • 5.1.2.1. Cost implications and investment obstacles affecting the GMP cell banking services
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements elevating the expectations for precision and reliability in GMP cell banking
      • 5.1.3.2. Development of regenerative medicine and immune therapies necessitating sophisticated cell banking repositories
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for GMP compliance and cell banking approvals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Cell Type: Expansion of personalized medicine and regenerative therapies boost the demand for human cells
    • 5.2.2. End-User: Increasing investments in the pharmaceutical & biopharmaceutical sector, enhancing their cell banking infrastructure,
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. GMP Cell Banking Services Market, by Cell Type

  • 6.1. Introduction
  • 6.2. Animal Cells
  • 6.3. Human Cells

7. GMP Cell Banking Services Market, by Quality Grade

  • 7.1. Introduction
  • 7.2. Clinical Grade
  • 7.3. Research Grade

8. GMP Cell Banking Services Market, by Service Type

  • 8.1. Introduction
  • 8.2. End-of-Production Cell Banking
  • 8.3. Master Cell Banking
  • 8.4. Working Cell Banking

9. GMP Cell Banking Services Market, by Application

  • 9.1. Introduction
  • 9.2. Biopharmaceutical Production
    • 9.2.1. Monoclonal Antibodies
    • 9.2.2. Recombinant Proteins
  • 9.3. Research & Development
    • 9.3.1. Cell Therapy
    • 9.3.2. Gene Therapy
    • 9.3.3. Stem Cell Research
  • 9.4. Tissue Engineering
    • 9.4.1. Bioprinting Technologies
    • 9.4.2. Organ Transplant Solutions
    • 9.4.3. Scaffold-Based Applications

10. GMP Cell Banking Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Organizations
  • 10.3. Hospitals
  • 10.4. Pharmaceutical Companies
  • 10.5. Research Institutes

11. Americas GMP Cell Banking Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific GMP Cell Banking Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa GMP Cell Banking Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. I Peace's breakthrough in GMP iPSC manufacturing sets new standards in regenerative medicine and personalized cell banking
    • 14.3.2. Strategic collaboration between CellSave Arabia and Sidra Medicine to enhance stem cell banking in Qatar, advancing regenerative medicine and healthcare accessibility
    • 14.3.3. REPROCELL USA's new facility strengthens GMP cell banking capabilities with advanced closed system technology
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 53Biologics
  • 2. Austrianova
  • 3. Cell Culture Company, LLC
  • 4. Charles River Laboratories
  • 5. Clean Cells
  • 6. Eurofins Scientific Limited
  • 7. ExcellGene SA
  • 8. Goodwin Biotechnology Inc.
  • 9. Kaneka Eurogentec S.A.
  • 10. Lonza Group Ltd.
  • 11. Merck KGaA
  • 12. NAOBIOS
  • 13. PackGene Biotech lnc.
  • 14. ProBio Biotech Corporation
  • 15. RoslinCT
  • 16. SGS Group
  • 17. SK pharmteco Inc.
  • 18. Takara Bio Inc.
  • 19. Texcell SA
  • 20. uBriGene Biosciences International Co.
  • 21. ViruSure GmbH
  • 22. Wacker Chemie AG
  • 23. WuXi Biologics

LIST OF FIGURES

  • FIGURE 1. GMP CELL BANKING SERVICES MARKET MULTI-CURRENCY
  • FIGURE 2. GMP CELL BANKING SERVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. GMP CELL BANKING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 4. GMP CELL BANKING SERVICES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. GMP CELL BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. GMP CELL BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GMP CELL BANKING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GMP CELL BANKING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-OF-PRODUCTION CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MASTER CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY WORKING CELL BANKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPRINTING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ORGAN TRANSPLANT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SCAFFOLD-BASED APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 201. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA GMP CELL BANKING SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY QUALITY GRADE, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA G